Adare Pharma Solutions, a global contract development and manufacturing organization (CDMO) focused on oral dosage forms, completed its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, innovators in nutrition, health, and beauty. The transaction represents an enterprise value of €275 million. dsm-firmenich intends to extend the availability of Lactéol, Adare Biome’s over the counter postbiotic supplement for relievi...